Regeneron Pharmaceuticals Inc (REGN) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 01 December 2025 | Trade in progress | -3.64% | |
| 02 October 2023 | 01 November 2024 | 2.62% | 2.42% |
| 01 November 2022 | 03 July 2023 | -5.41% | -7.99% |
| 02 August 2021 | 01 July 2022 | 2.50% | 2.75% |
| 02 January 2020 | 01 December 2020 | 37.10% | 41.17% |
| 02 January 2019 | 01 May 2019 | -7.66% | -21.7% |
| 04 September 2018 | 01 November 2018 | -14.25% | -62.63% |
| 01 May 2017 | 01 November 2017 | 2.02% | 4.07% |
| 01 September 2016 | 01 November 2016 | -12.19% | -54.65% |
| Total Return | 1.09% | ||
The monthly data for Regeneron Pharmaceuticals Inc (exchange: XNAS symbol: REGN) was last updated 27 Mar 2026 11:34. Data for this stock is available from 01 Apr 2016 - 26 Mar 2026.
